E Fund Management Co., Ltd. Curis Inc Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.31 - $5.13 $45,058 - $100,065	-19,506 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.45 - $8.09 $1,628 - $2,960	-366 Reduced 1.84%	19,506 $93,000
Q3 2021 Nov 12, 2021	BUY	$6.94 - $8.85 $49,787 - $63,489	7,174 Added 56.5%	19,872 $156,000
Q1 2021 May 12, 2021	BUY	$8.78 - $12.8 $111,488 - $162,534	12,698 New	12,698 $143,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $291M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.